I'm out and about but the one difference I could find is that they changed the revenue forecast band for 2019 from A$ 17-26m to 20-26m? Otherwise nothing new in there at first glance.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025